Next, we conducted a prognostic correlation analysis of DTX2 using the TCGA glioma cohort; our results showed that DTX2 had favorable prognostic value within this cohort, particularly with respect to overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI) patterns (Fig. 1E). The gene discussed is DTX2; the disease is glioma.